Breaking News, Collaborations & Alliances

Charles River, CELLphenomics Partner on 3D In Vitro Services

CELLphenomics’ PD3D tumor model platform will expand Charles River’s portfolio of 3D in vitro testing services.

Charles River Laboratories entered into an agreement with CELLphenomics, a service-based biotechnology company using 3D hydrogel technology to advance the understanding of the tumor microenvironment and predict therapeutic efficacy. The enhanced offering will provide Charles River clients with access to CELLphenomics’  3D tumor model platform to further optimize oncological approaches for its clients. Leveraging CELLphenomics technology, Charles River will now have a novel in vitro option for...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters